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Objectives. This study was designed to investigate the organ
ad disease specificity of antiheart antibodies in patients with
dilated cardiomyopathy .
ckgro . Autolmmune disease Is characterized by the
presence of circulating autoaatf dies, and autoimmune mecha-
may play a role in the pathogenesis of dilated cardiomyop .
athy.
Methods. An SDS-PAGE (sodium dodecylsulfate polyacryl-
ide gel electrophoresis) procedure followed by Western blotting
was used to screen serum samples for antiheart antibodies of two
immu lobulin , IgM and IgG, from 52 patients with
dilated cardiomyopathy and 48 patients with ischemic heart
disease as control subjects . Use of two-dimensional gel electro-
phoresis followed by Western blotting and protein sequencing
enabled us to identify the protein bands against which antiheart
antibodies were produced in both groups of patients .
Results. Strong lgG antiheart antibodies against myocardial
proteins, cross-reacting with skeletal muscle proteins, were de.
Dilated cardiomyopathy remains one of the most poorly
understood and underexplored cardiovascular disease
states. Immunologic investigation is playing an increasingly
important role in determining its etiology . Autoimmune
disease is characterized by the presence of autoantibodies,
and an immune mechanism may be involved in the patho .
genesis of dilated cardiomyopathy .
Several types of autoantibodies against heart muscle and
other autoantigens have been documented in dilated cardio-
myopathy, indicating a diffuse alteration in the immune
system. Autoantibodies to the heart have identified the
beta 1-adrenergic receptor (1), the M7 mitochondrial antigen
(2), the adenine nucleotide translocator (3-5) and myosin
heavy chain (6) as potential cardiac antigens .
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CARDIOMYOPATHY
tected in significantly more patients with dilated cardiomyopathy
(n = 24 146%]) than with ischemic heart disease (n » 8117%!)
(p 0.601). Patients with dilates!d cardiomynpatby showed a
significantly greater frequency and reactivity of lgG antiheart
antibodies against six myocardial proteins (molecular weight 30,
35, 40, 60, 85 and 200 kD) than did patients with ischemic heart
disease. These were identified as myosin light chain 1, tro myo-
sin, actin, heat shock protein (IISP)-60, an unidentified protein
and myosin heavy chain, respectively .
Conclusions. We detected strong IgG antiheart antibodies in
significantly more patients with dilated cardiomyopathy than with
ischemic heart disease . The most Imntunogenic band was that
corresponding to IISP-60 . Antibodies against HSP.60 were found
in 85% and 42 of patients with dilated cardiomyopathy and
ischemic heart disease, respectively, confirming our hypothesis of
an immune Involvement in dilated cardiomyopathy.
(J Am Coll Cardiol 1993,22:1378-84)
In a previous limited study (7) of antiheart antibodies
before and after heart transplantation, we showed a greater
prevalence of weak antiheart antibodies in patients with
ischernic heart disease, but the two cases of strong antiheart
antibodies of the immunoglobulin IgG class were both asso-
ciated with dilated cardiomyopathy . The aim of this study
was to determine the organ and disease specificity of anti-
heart antibodies in patients with dilated cardiomyopathy or
ischemic heart disease and in normal disease-free persons
and then characterize the antigens
Methods
Pieces of ventricular myocardium from the explanted
heart of 10 recipient patients were obtained at the time of
transplantation . The banding pattern from immunoblotting
results was not dependent on the original diagnosis . The
myocardial pieces were immediately frozen in liquid nitro-
gen. Skeletal muscle was obtained from patients undergoing
routine cardiac surgery .
Control sera were collected from 18 laboratory workers
(8 men, 10 women [mean age 32 years, range 18 to 431) .
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Serum samples were collected from patients diagnosed with
dilated cardiomyopathy or ischemic heart disease . All serum
samples were stored at -20°C .
Patients . The dilated cardiomyopathy group included 52
patients (40 men, 12 women [mean age 42 years, range 5 to
651) . To confirm the diagnosis, all patients underwent an
assessment that included a medical history, drug therapies,
clinical investigations, two-dimensional echocardiography,
fractional shortening, cardiac catheterization, evaluation of
hemodynamic function and coronary arteriography . Left
ventricular end-diastolic and end-systolic dimensions were
47 to 89 mm (mean 70 .37) and 33 to 77 mm (mean 61 .94),
respectively . Fractional shortening was 2% to 30% (mean
12.48%), left atrial internal dimensions were 32 to 60 min
(mean 43 .78) and ejection fraction was 9% to 66% (mean
3115%
Forty-eight patients (44 men, 4 women 'mean age 55
years, range 35 to 69]) with ischemic heart disease were
studied. Of these 48 patients, 18 had had a documented
myocardial infarction 3 to I S years before the time of so am
sampling . The ejection fraction for this group was 10 1;'c., to
45% (mean 30 .8%) .
Serum samples were collected from patients just before
heart transplantation . There was no significant difference in
hemodynamic severity between the group of patients with
dilated cardiomyopathy and those with ischemic heart dis-
ease .
Eighteen normal disease-free subjects (8 men, 10 women
[mean age 32, range 18 to 431) were used as a control group
for comparative purposes .
SDS-PAGE. Samples of ventricular myocardium and
skeletal muscle were prepared according to the technique
described by Dunn et al . (7) . Ventricular myocardium and
skeletal muscle proteins (total weight 25 Ag) were separated
on 7-cm long 10% T (total concentration of acrylamide plus
bis-acrylamide in gm/100 ml) SDS-PAGE (sodium dodecyl
sulfate polyacrylamide gel electrophoresis) gels with a 3% T
stacking gel .
Two-dimensional polyacrylamide gel electrophoresis . In
this procedure, separations of 600-Ag samples of myocardial
proteins were performed using the Millipore Investigator
two-dimensional electrophoresis system (8) .
Western blotting. Before electroblotting, the gels were
equilibrated for 30 min in transfer buffer (20 mmol/liter Tris
base, 150 mmol/liter glycine) . For one- and two-dimensional
gels, the proteins were electrophoretically transferred to
supported nitrocellulose (Hybond C Super, Arrersham In-
ternational) at 500 mA for I h or at 400 mA for 14 h,
respectively .
Detection of antiheart antibodies. Nitrocellulose mem-
branes carrying lanes of myocardial and skeletal proteins
separated by SDS-PAGE and myocardial proteins separated
by two-dimensional PAGE were probed according to a
previously described technique (7) . Serum was used at a
concentration of 1/200 and secondary antibodies were used
at 1/500 and 1/1,000 for the immunoglobulin classes IgG and
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IgM, respectively . Visualization of the protein bands to
which antiheart antibodies had bound was accomplished
using an enhanced chemiluminescence detection system
(Amersham International) . Blots were incubated with the
detection reagent for I min and then exposed to Hyperfilm
ECL for 1, 2 and 5 min . The films were developed using an
automated radiograph developer .
Protein sequencing. For N-terminal protein sequencing, a
two-dimensional separation of heart proteins was transferred
onto a FluoroTrans membrane (Pall) . The blotting buffer was
50-mmoUliter'rris base, 50 mmollliter boric acid, pH 8 .5, and
the transfer was carried out at 400 mA for 14 h and then
stained with Coomassie Brilliant Blue. The spots of interest
were excised from the blot and placed into a New Blott
cartridge (ABI) fitted to an ABI model 477A pulsed liquid
protein sequencer equipped with a model 120A PTH ana-
lyzer. Proteins were sequenced using the optimized blot
pro &' ialn (V) .
Stripping membranes, For the localization of protein
spots after immunoprobing, the two-dimensional blots were
stripped of primary and secondary antibodies and then
stained using Amido Black . The blots were incubated in
stripping solution (100 mmol/liter 2-mercaptoethanol, 2%
weight/volume sodium dodecyl sulfate, 62 .5 mrnol/liter 'iris
chloride, pH 6.7) for 30 min at 50°C with occasional agita-
tion . The membranes were then washed thoroughly in
phosphate-buffered saline-Tween solution and stained with
Amido Black .
Isolation and purification of myofibrils . Myofibrils were
isolated and prepared according to the method described by
Solaro et al . (9) .
Data analysis. A Fisher exact test was used to compare
the positive results in both groups of patients . A p value of
< 0.05 was considered statistically significant .
Resulds
All sera, dilated cardiomyopathy, ischemic heart disease
and normal disease-free samples, whether positive or nega-
tive for antiheart antibodies, showed a background band that
had a molecular weight of 70 or 50 M depending on whether
the secondary antibody was peroxidase-conjugated IgM or
IgG (Fig . I to 3) . This band was caused by the binding of the
IgM and IgG secondary antibody to their respective immu-
noglobulin heavy chains contained in the myocardial and
skeletal muscle samples .
Normal sera showed minimal if any reactivity against
myocardial and skeletal proteins . Eight samples (44%) tested
negative and 10 (55%) weakly positive for IgM reactivity and
I I samples (61%) tested negative and 7 (39%) weakly posi-
tive for IgG reactivity (Fig . 1) . None of the normal samples
showed medium or strong antibodies of either the 1gM or the
IgG class . Of the 10 samples weakly positive for IgM
reactivity, 4 (22%) were positive for the 35-kD band and 2
(11%) for the 200-kD band
. Of the seven samples (39%)
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Figure 1 . Three Western blots showing minimal antiheart antibody
reactivity against heart proteins in duplicate from three volunteer
control serum samples . Sample I shows negative results and sam-
ples 2 and 3 show a weak band at 03 kD . Sample 2 shows an
additional band at 40 kD . The band indicated with an arrowhead
represents the presence of the immunoglobulin IgG class in the heart
samples. The scale at the left indicates relative molecular mass x
101 .
weakly positive for IgG reactivity, three (16%) were positive
for the 35-kD band and four (22%) for the 20-kD band .
Forty-four patients (85%) with dilated cardiomyopathy
and 46 patients MOM with ischemic heart disease tested
positive for antiheart antibodies of the IgM class . All 48
patients (100%) with dilated cardiomyopathy and 45 patients
(96%) with ischemic heart disease tested positive for anti-
re 2. Three Western blots showing weak lgCj immunoglobulin
andheart antibody reactivity against heart (H) and skeletal (S)
muscle in duplicate from three patients with ischemic heart disease .
Each blot represents one patient . Patient I shows strong antiheart
antibodies against a 0•kD band in both heart and skeletal muscle
and Patient 2 shows two skeletal-specific bands of 35 kD and
reactivity to a band at 200 kD in heart and skeletal muscle . The band
indicated with an wrowheW represents the presence of IgG in the
heart and skeletal muscle samples . The scale at the left indicates
relative molecular mass x 101.
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Figure 3. Three Western blots showing strong IgG immunoglobulin
antiheart antibody reactivity against heart (H) and muscle skeletal
(S) in duplicate from three patients with dilated cardiomyopathy .
Each blot represents one patient. All three patients show a faint
hand at 30 kD and strong bands at 35, 40, 60 and 200 kD. Patient 2
shows an additional strong hand at 85 kD . I he band indicated with
an arrowhead represents the presence of IgG in the heart and
skeletal muscle samples . The scale at the left indicates relative
molecular mass x 10 - .
heart antibodies of the IgG class . There were no significant
differences between the two groups of patients in testing
positive for antibodies of either the IgM or the lgG class .
The positive results were graded according to the strength
of the reactions (intensity and number of reactive bands) as
weak, medium and strong antiheart antibodies (Tables I and
2) .
There were no significant differences between the two
groups of patients regarding the strength of IgM antibodies
(Table 1) . Most patients with dilated cardiomyopathy (46%)
and ischemic heart disease (50%) showed weak 1gM antibod-
ies; however, there were significant differences in the pro-
duction of IgG antibodies (Table 2) .
Significantly more patients with ischemic heart disease
than with dilated cardiomyopathy had weak antiheart anti-
bodies of the IgG class (Fig . 2), and significantly more
patients with dilated cardiomyopathy than with ischemic
heart disease had strong andheart antibodies of the IgG class
(Fig. 3). All patients with dilated cardiomyopathy tested
Table 1
. Strength of IgM Antiheart Antibodies in Patients With
Dilated Cardiomyopathy and Ischemic
Heart Disease
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-VE = negative (no antiheart antibodies detected)
.
Strength
of Antibody
Dilated
Cardiomyopathy
Ischemic
Heart Disease
Fisher
Exact Test
No. %
No . %
-VE
8 15 .5 2
4 0.060
Weak
24 46 24
50 0.426
Medium 13
25 15 31
0.318
Strong
7
13 .5 7 15 0.549
JACC Vol . 22, No . 3
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Table 2. Strength of IgG Antiheart Antibodies in Patients With
Dilated Cardiomyopathy and Ischernic Heart Disease
*Significant . -VE = negative (no antibeart antibodies detected) .
positive for IgG antibodies, whereas 8 patients (15 .5%) with
dilated cardiomyopathy tested negative for IgM antibodies .
In both patient groups, reactivity against protein bands
was tabulated according to the molecular weight of the
bands. Antibodies of the IgNI and the IgG class were
produced against I I and 12 distinct bands, respectively .
There were no differences in the frequency of IgAM antiheart
antibodies between the patients with dilated cardiomyopathy
and ischemic heart disease (results not shown) . However,
the patients with dilated cardiomyopathy showed a ,gnifi-
cantly greater frequency (p < 0 .05) and reactivity of IgG
antiheart antibodies against six myocardial proteins (molec-
ular weight 30, 35, 40, 60, 85 and 200 kD) (Fig . 2) than did
patients with ischemic heart disease (Table 3) .
Antibodies cross-reacting with skeletal muscle . All of the
reactivities against the six myocardial proteins cross-reacted
with skeletal muscle proteins . However, the band of reac-
tivity against myocardial proteins was always of greater
intensity than that against skeletal muscle proteins .
Four patients with dilated cardiomyopathy and seven
with ischemic heart disease produced some skeletal muscle-
specific bands . One of the four patients with dilated cardio-
myopathy showed a skeletal muscle-specific band of the
IgM class . Regarding IgG skeletal muscle-specific bands,
Table 3. Frequency of lgCY Antiheart Antibodies in Patients With
Dilated Cardiorayopathy and Ischemic Heart Disease
*Significant .
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Figure 4
. This shows an SDS-PAGE gel (A) stained with Coomassie
Brilliant Blue and two blots (B) of heart (H) and myofibrillar (M)
proteins probed using sera from two patients with dilated cardiomy-
opathy
. Patients I and 2 show reactivities against myofibrillar bands
of 30, 35, 40 and 200 kD
. The band indicated with an arrowhead
represents the presence of immunoglobulin (IgG) in the heart
samples, which is absent in the purified myofibrillar preparation
.
The scale at the left indicates relative molecular mass x 10''
one patient showed one band of the IgG class against a 30-kD
band, one patient showed two skeletal muscle-specific
bands (one of 30 kD and one of 35 kD) and one patient
showed one skeletal muscle-specific band of 35 kD . Of the
seven patients with ischemic heart disease showing skeletal
irriscle-specific bands, six showed reactivity against a 30-kD
band of the IgM class and one patient showed reactivity
against a 35-kD band of the IgG class .
Characterization of reactive bands . To ascertain whether
any of these reactive bands were myofibrillar proteins, sera
from patients with dilated cardiomyopathy were tested
against a purified preparation of myofibrils . Of all the bands
listed in Table 3, the only bands of the myofibrillar protein
fraction reactive with sera from patients with dilated cardio-
ruyopathy were the 30-, 35-, 40- and 200-kD bands (Fig. 4) .
These bands were hence categorized as being myofibrillar
proteins. On the basis of their molecular weight, likely
candidates for these bands are myosin light chain 1, tropo-
myosin, actin and, probably, myosin heavy chain, respec-
tively .
To further characterize the proteins reactive with anti-
bodies prevalent in the dilated cardiomyopathy sera, two-
dimensional blots were probed using sera showing IgG
antibodies to the bands of interest . Two-dimensional pat-
terns of heart proteins (Fig . 5) and myofibrillar proteins (Fig .
6) were silver stained for use as a reference. The major
proteins on this two-dimensional separation of myofibrillar
proteins were desmin, actin, tropomyosin, myosin light
chain I and myosin light chain 2
. Sera from patients with
dilated cardiomyopathy were reacted with two-dimensional
blots and any reactions were recorded on Hyper
film .
Strength
of Antibody
Dilated
Cardiomyopathy
Ischemic
Heart
Disease
%
Fisher
Exact TestNo . % No .
-VE 0 0 3 6 0 .107
Weak 17 33 28 58 0 .008*
Medium 11 21 9 19 0.480
Strong 24 46 8 17 0 .001*
Molecular Weight
of Protein (kD)
Dilated
Cardiomyopathy
Ischemic
Heart Disease
Fisher
No . No . % Exact Test
30 9 17.3 0 0 0 .004*
35 29 55 10 20.8 0.0003*
40 37 71 10 20 .8 < 0.001*
46 2 3 .8 0 0 0 .26
60 44 84 .6 20 42 < 0 .001*
70 3 5 .1 2 4 .1 0 .54
85 27 52 7 14 .5 < 0,001"
100 7 13 .5 10 20 .8 0.24
120 22 42 4 29 02
150 13 25 8 16 .6 0.22
180 14 27 8 16 .6 0.16
200 35 67 20 42 0.0086*
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Figure S. A two-dimensional silver-stained separation of heart pro-
teins, The I represents the isoclectric focusing dimension with the
acidic proteins on the left and the basic proteins on the right ; 2
represents the molecular weight dimension with the high molecular
weight proteins at the top and the low molecular weight proteins at
the bottom of the gel,
The 30-kD band was confirmed as myosin light chain I
(Fig . 7a), the 35-kD band as tropomyosin (Fig . 7b) and in
most cases the WD band as actin (Fig. 7c), but in a few
cases two spots under actin were reactive with antibodies in
dilated cardiomyopathy sera and these remain as yet uniden-
tified . Antibodies against the 60-kD band reacted with two
spots on the two-dimensional blots (Fig . 7d). These spots
were excised from a Coomassie Blue-stained two-
dimensional blot on a FluoroTrans membrane and N-
terminal sequence analysis was performed . The first 20
amino acids sequenced are shown here in single letter code :
AKDVK,"GA, D .~.RALMLQGVDL .
A search was then made for homologies with known
sequenced proteins, and a 100% homology was found with
heat shock protein (HSP)-60. To confirm this finding, two
antibodies were obtained, one against mycobacteriall HSP-65
(a gift of Dr . J . Ivanyi) and LK-1, which is against human
HSP-60 (a gift of Dr. W, Van Eden) . Both antibodies reacted
Rpre 6 . A two-dimensional silver-stained separation of myofibril-
far proteins . The spots indicated by the arrowheads are, from top to
bottom, desmin, actin, tropomyosin, myosin light chain I and
myosin light chain 2 . Numbers and format as in Figure 5 .
I
I
Wd
dw -
CP. -f-
aw -0
Figure 7 . Two-dimensional blot of heart proteins probed using
serum frown a patient with dilated cardiomyopathy . Many spots can
be seen, but the spots that were detected most often using sera from
patients with dilated cardiomyopathy are indicated with arrowheads;
a, Myosin light chain 1 : b, tropoinyosin ; c, actin ; d, lisp-60;
e, unidentified . Numbers and format as hi Figure 5 .
exclusively with the two spots identified using dilated car-
diomyopathy sera positive for a 60-kD band (Fig . 8). This
band was hence identified as hHSP-60 .
The 85-kD band has also been identified on two-
dimensional blots (Fig. 7e), but on sequencing it was found
to have a blocked N-terminus . Further characterization of
this protein will require internal protein sequence analysis .
Discussion
This study presents a systematic evaluation of antiheart
antibodies in sera from patients with dilated cardiomyopathy
or ischcmic heart disease and normal, healthy, volunteer
control subjects . Our results have demonstrated that a large
number of autoantibodics are generated in patients with
dilated cardiomyopathy .
The principal procedure utilized here was Western blot-
ting. A number of studies have confirmed our own findings
(7) that immunofluorescence is less sensitive than Western
Figure 8 . A two-dimensional blot of heart proteins probed using the
monoclonal antibody LK-I against human heat shock-60. Numbers
and format as in Figure 5 .
2 0
JACC Vol. 22, No
. 5
November 1 . 1993 :1378-84
-00
JACC Vol. 22, No. 5
November I, 1993 :1378-94
blotting in detecting antiheart antibodies (6,10) and that this
type of screening procedure is unlikely to identify any single
cardiac antigen . Moreover, Western blotting has the advan-
tage that reactive antigens can be subsequently identified by
the use of molecular weight markers, polyclonal and mono-
clonal antibodies and direct protein microsequencing .
A large variety of bands were detected by Western
blotting in patients with dilated cardiomyopathy . Eleven
bands were reactive with IgM and 12 with IgG antibodies .
These bands were also found in patients with ischemic heart
disease but at significantly lower frequencies . Sera from
patients with dilated cardiomyopathy were further charac-
terized against myofibrillar proteins, likely candidates being
myosin light chain 1, tropornyosin, actin and myosin heavy
chain . The identity of these bands was confirmed by probing
two-dimensional blots of heart proteins, which revealed
more, as yet unidentified, bands . The most commonly found
antibodies were against a 60-kD band (Table 3) ; these were
present in 85% and 42% of patients with dilated cardioirly-
opathy and ischemic heart disease, respectively . Two
dimensional gel analysis and protein sequencing revealed
100% homology of this peptide with HSP-60. Heat shock
proteins are highly conserved immunogenic molecules
whose cellular levels are elevated by heat, inflammatory
mediators and all forms of physiologic stress (11, 12) . Heat
shock proteins are thought to protect cells from damage
during stressful conditions (13) .
Autoantibodies and T cells reactive with heat shock
proteins have been described in patients with rheumatoid
arthritis, systemic lupus erythematosus and more recently in
patients with schizophrenia (14) and inflammatory diseases
of the bowel 05) .
The presence of circulating antibodies against HSP-60 in
85% of patients with dilated cardiomyopathy is clear evi-
dence of a damaged myocardium . The exact pattern and
distribution of HSP-60 in normal and diseased myocardium
has not yet been established . We are currently using both
Western blotting to assess whether HSP-60 is upregulated in
disease states and immunocytochemistry to investigate its
precise localization on frozen specimens .
Thus, our study has positively identified reactions against
the major contractile proteins as well as noncontractile
proteins such as HSP-60 . Although Caforic et al . (6) sug-
gested that myosin is the major autoantigen in dilated
cardiomyopathy, the present study does not support this
conclusion . Antimyosin antibodies were found in 67% of
patients with dilated cardiomyopathy but also in 42% of
patients with ischemic heart disease . It may be that the
diversity of autoantibodies found in patients with dilated
cardiornyopathy is more important than reactivity of one
particular specificity in the pathogenesis of dilated cardio-
myopathy. We have not detected antiheart antibodies re-
ported in previous studies against the beta 1 -adrenergic re-
ceptor (1), the adenine nucleotide translocator (3-5) or the
M7 mitochondrial antigen (2) . This may be explained by the
use of enriched membrane and rnitochondrial fractions in
LATtF ET AL .
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previous studies, in contrast to the total cardiac homogenate
used in our study .
Not all antiheart antibody reactivity detected was found
to be cardiac specific . This is not surprising because cardiac
and skeletal muscle share the majority of their proteins,
varying only in the different isoforms of each protein . In
humans, two types of myosin heavy chain are present in the
atria and ventricles (16) . These two can be classified as alpha
and beta types . Immunochemical examination (16) and im-
munoaffinity chromatography (17) of human cardiac myosin
has shown that myosin heavy chain-beta predominates in the
ventricle and is also present in slow skeletal muscle and both
are encoded by the same gene (18) . It is therefore not
surprising that the antibodies detected against myosin heavy
chain-beta cross-react with the skeletal muscle myosin .
Actin has many isoforms (19). The sarcomeric actins,
alpha-skeletal and alpha-cardiac, are expressed only in skel-
etal and cardiac muscle . The cardiac actin differs from
skeletal muscle alpha-actin only at four amino acid residues
(20), and antibodies detected by Western blotting against
actin could not distinguish between the two isoforms .
Two main isotypes of tropomyosin (alpha and beta) exist
in striated muscle (21,22) . In the human ventricle, the alpha
isotype constitutes 90 .6% of the total tropomyosin (23) . The
fact that the cardiac alpha isotype has a primary sequence
identical to that of the skeletal form (24,25) explains why one
band and two bands were seen in the cardiac and skeletal
lanes, respectively, and that antibodies recognized both the
cardiac and the skeletal isoforms .
The major myosin alkali light chain of adult heart ventri-
cles, myosin light chain 1, has been shown by one- and
two-dimensional gel electrophoresis and partial peptide anal-
ysis to be very similar to the skeletal slow muscle isoform
myosin light chain Is (26) . Ventricular myosin light chain I
has a molecular weight of approximately 28 kD, but skeletal
muscle myosin light chain I has an approximate molecular
weight of 25 kD, explaining why a corresponding band was
not detected alongside the ventricular myosin light chain 1 .
This cross-reactivity of antiheart antibodies may explain
why some of these patients have subclinical skeletal myop-
athy . Caforio et al . (27) studied patients with dilated cardio-
myopathy and patients with hypertrophic cardiomyopathy .
In -37% of patients in both groups, there was an abnormal
reduction of skeletal motor unit potential duration indicative
of myogenic myopathy . It would be interesting to absorb our
sera with skeletal muscle to determine which bands are
specific for cardiac muscle .
A number of studies (1-6) have now documented au-
toantibodies against heart muscle . These observations raise
three important questions : 1) Does the autoantihody profile
of a patient have any diagnostic or prognostic value? 2) Are
the antibodies primarily involved in development of the
disease or are they formed secondary to infection cr myo-
cardial injury? 3) Are the antibodies produced as a result of
the release of sequestered antigens, induction of neoanti-
gens, molecular mimicry or alteration in the host's immune
JACC Vol . 22, No . 5
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responses (28,29). It would be of value to test all the putative
antigens in an enzyme-linked immunosorbent assay so that
quantitative data can be produced . In this way, the relative
importance of the antigens as diagnostic markers of disease
could be assessed . Some functional studies (30-32) have
already established that antiheart antibodies can cause car-
diac dysfunction . Thus, antibodies directed against the ade-
nine nucleotide translocator enhanced intracellular calcium
transport when added to isolated beating cardiac myocytes,
and immunization of guinea pigs with purified adenine nu-
cleotide translocator induced abnormal adenine nucleotide
translocator-carrier function in vivo (31) and caused marked
impairment in cardiac function in vivo (32) .
Future work should aim at establishing whether these
antibodies can be damaging against a human fetal cardiac
myocyte cell line (33) or isolated adult human cardiac
myocytes. We intend to elute antibodies from nitrocellulose
blots to determine whether antibodies against different car-
diac peptides are damaging, using isolated human cardiac
myocytes as targets .
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